The crystal structure of 2-(naphthalen-2-yloxy)-4-phenyl-6-(prop-2-yn-1-yloxy)-1,3,5-triazine, C22H15N3O2
Author:
Li Jin12ORCID, Zuo Zhenyu32, Chen Yan2, Liu Yali1, Yin Dachuan1
Affiliation:
1. Institute for Special Environmental Biophysics, Key Laboratory for Space Bioscience and Space Biotechnology, School of Life Sciences, Northwestern Polytechnical University , Xi’an 710072 , Shaanxi , PR China 2. Shaanxi Key Laboratory of Basic and New Herbal Medicament Research , Xi’an , 712046 , PR China 3. College of Pharmacy, Shaanxi University of Chinese Medicine , Xi’an , Shaanxi , 712046 , PR China
Abstract
Abstract
C22H15N3O2, triclinic,
P
1
‾
$P‾{1}$
(no. 2), a = 5.7613(4) Å, b = 12.3545(7) Å, c = 13.3427(8) Å, α = 110.002(2)°, β = 98.837(2)°, γ = 94.263(2)°, V = 873.55(9) Å3, Z = 2, Rgt
(F) = 0.0471, wRref
(F
2) = 0.1376, T = 293 K.
Funder
National Key R&D Program of China National Natural Science Foundation of China Shaanxi Key Laboratory of Basic and New Herbal Medicament Research Key R&D plan of Shaanxi Province
Publisher
Walter de Gruyter GmbH
Subject
Inorganic Chemistry,Condensed Matter Physics,General Materials Science
Reference14 articles.
1. Bruker. APEX2, SAINT and SADABS; Bruker AXS Inc.: Madison, Wisconsin, USA, 2012. 2. Sheldrick, G. M. Crystal structure refinement with ShelXL. Acta Crystallogr. 2015, C27, 3–8. 3. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K., Puschmann, H. Olex2: a complete structure solution, refinement and analysis program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726. 4. Kothayer, H., Spencer, S. M., Tripathi, K., Westwell, A. D., Palle, K. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors. Bioorg. Med. Chem. Lett. 2016, 26, 2030–2034; https://doi.org/10.1016/j.bmcl.2016.02.085. 5. Cascioferro, S., Parrino, B., Spano, V., Carbone, A., Montalbano, A., Barraja, P., Diana, P., Cirrincione, G. 1,3,5-Triazines: a promising scaffold for anticancer drugs development. Eur. J. Med. Chem. 2017, 142, 523–549; https://doi.org/10.1016/j.ejmech.2017.09.035.
|
|